BIVIX
Price
$16.91
Change
+$0.02 (+0.12%)
Updated
Dec 23 closing price
QLENX
Price
$15.67
Change
+$0.01 (+0.06%)
Updated
Dec 23 closing price
Ad is loading...

BIVIX vs QLENX

Header iconBIVIX vs QLENX Comparison
Open Charts BIVIX vs QLENXBanner chart's image
Invenomic Institutional
Price$16.91
Change+$0.02 (+0.12%)
VolumeN/A
CapitalizationN/A
AQR Long-Short Equity N
Price$15.67
Change+$0.01 (+0.06%)
VolumeN/A
CapitalizationN/A
BIVIX vs QLENX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIVIX vs. QLENX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVIX is a Hold and QLENX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 2.21B vs. BIVIX (1.07B). QLENX pays higher dividends than BIVIX: QLENX (18.52) vs BIVIX (2.62). BIVIX was incepted earlier than QLENX: BIVIX (8 years) vs QLENX (11 years). BIVIX is a more actively managed with annual turnover of: 140.00 vs. QLENX (0.00). QLENX has a lower initial minimum investment than BIVIX: QLENX (2500) vs BIVIX (50000). QLENX annual gain was more profitable for investors over the last year : 30.04 vs. BIVIX (-10.83). QLENX return over 5 years is better than : 102.74 vs. BIVIX (58.73).
BIVIXQLENXBIVIX / QLENX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years11 years-
Gain YTD-10.91730.443-36%
Front LoadN/AN/A-
Min. Initial Investment5000025002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B2.21B48%
Annual Yield % from dividends2.6218.5214%
Returns for 1 year-10.8330.04-36%
Returns for 3 years5.1187.766%
Returns for 5 years58.73102.7457%
Returns for 10 yearsN/A124.94-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZG73.38-0.39
-0.53%
Zillow Group
ABUS3.19-0.02
-0.62%
Arbutus Biopharma Corp
VS2.14-0.04
-1.83%
Versus Systems
PTGX40.60-0.89
-2.15%
Protagonist Therapeutics
CXAI1.55-0.04
-2.52%
CXApp